On February 13, 2024, The Cigna Group completed its previously announced offering of $1.0 billion in aggregate principal amount of its 5.000% Senior Notes due 2029, $750 million in aggregate principal amount of its 5.125% Senior Notes due 2031, $1.25 billion in aggregate principal amount of its 5.250% Senior Notes due 2034 and $1.5 billion in aggregate principal amount of its 5.600% Senior Notes due 2054 (together with the 2029 Notes, the 2031 Notes and the 2034 Notes, the Notes). The Notes were sold pursuant to the Company?s shelf registration statement on Form S-3ASR (File No. 333-268633).

The terms of the Notes are governed by an Indenture, dated as of September 17, 2018 (the ?Base Indenture?), between the Company and U.S. Bank Trust Company, National Association, as successor to U.S. Bank National Association, as trustee, as supplemented by Supplemental Indenture No. 7 to the Base Indenture, dated as of February 13, 2024, between the Company and the Trustee.